Archive for the ‘BVI company investments’ Category

AgeX Therapeutics and its BVI-registered investor Juvenescence Ltd. announced publication of paper on the engineering of universal cells

Saturday, November 2nd, 2019

Juvenescence Ltd., BVI-registered science company developing technologies to treat aging, and AgeX Therapeutics, Inc., a biotechnology company developing therapeutics for human aging and regeneration, announced the publication of a new paper in the scientific journal Regenerative Medicine. The published paper is on the strategies of engineering of allogeneic cells to be hypoimmunogenic (universal), so as not to produce an immune response. Also, the paper presents previously unpublished observation in vivo on allogeneic human stem cells (hPSCs).

The leading author of the paper is Dr. Nafees Malik, Chief Operating Officer at AgeX and Head of Cell & Gene Therapy at Juvenescence, which is a major investor in AgeX. His co-authors on the paper are Gregory Bailey, MD, Chairman of the Board of Directors of AgeX and CEO of Juvenescence; Annalisa Jenkins, MBBS, FRCP, who serves on the Board of Directors of AgeX; and Jim Mellon, Chairman of Juvenescence.

Dr Malik said in his comments on the publication: “This is a huge area of focus for us at AgeX, via our UniverCyte technology platform. In support of our own research and as a service to the overall field, we decided to put together this paper, analyzing all the leading strategies to engineer universal cells and encapsulating them in one paper.”

BVI Government seeks new investors for hotel, after failure of deal with CA (BVI) Group Corp

Wednesday, May 1st, 2019

The VIP government is seeking new investors for redevelopment of the state-owned Prospect Reef Hotel, as the previous US$90 million deal between NDP administration and ICA (BVI) Group Corp signed in July 2017 has not materialized. Junior Tourism Minister Shereen Flax-Charles announced during the budget debate that prospective investors appeared at a recent tourism conference; also, by words of BVI Premier Fahie, many persons have interest about the hotel and continue to make contact with the BVI government.

Meanwhile, Third District Representative Julian Fraser urged the new government to pay the employees of the resort, as there are security guards who are not being paid. Also, he asked the government to give the facility some attention: “Prospect Reef has been a benefit to no one for the last 15 years. We cannot afford to lose those kinds of facilities. We are a tourism-oriented economy, and those are the things that we need. We don’t go back when it comes to development and efforts should be made in getting investors involved in bringing those things to life.”

The previous developers, ICA (BVI) Group Corp, had the plans to construct 150 rooms, condos/townhouses, a marina, conference centre, parking lots, a dolphin attraction, infinity pool, salt water pool, and villas. They received an extension from the NDP government, which expired on March 31, 2019.

BVI holding Juvenescence Ltd founded Napa Therapeutics in cooperation with Buck Institute and Insilico Medicine

Thursday, August 16th, 2018

BVI-registered Juvenescence Ltd, which is focused on ageing research and therapy investments, together with the Buck Institute for Research on Aging and Insilico Medicine have formed Napa Therapeutics, Ltd. – a biotechnology company focused on a novel target linked to one of the fundamental processes of ageing, and developing molecule drugs to address this target.

Napa Therapeutics is based on an innovative research in NAD metabolism conducted in the laboratory of Eric Verdin, President and CEO of the Buck Institute – and independent non-profit institution which is one of the main research centres focused on the problems of ageing and age-related diseases. Napa is a privately held British Virgin Islands company having an office in the Isle of Man.

Insilico Medicine is an artificial intelligence company with offices and resources in the US, Belgium, Russia, the UK, Taiwan and Korea. The Verdin lab will collaborate with Napa Therapeutics and use Insilico’s drug development engine to speed the discovery of new compounds.

HK skyscraper sold to BVI company in US$5.2mln deal

Tuesday, November 7th, 2017

Hong Kong tycoon’s company Li Ka-shing’s CK Asset Holdings has sold its stake in The Center, the fifth-tallest skyscraper in Hong Kong, for the amount of US$5.2 billion. Thus, the 73-story building was purchased for the record sum for a commercial property in HK. CK Asset Holdings said it expects to make a profit of US$1.9 billion (HK$40.2 billion).

The purchaser is C.H.M.T. Peaceful Development Asia Property Limited, an investment vehicle incorporated in the British Virgin Islands specially for this purpose. According to the market sources, the company’s largest shareholder is Beijing-based China Energy Reserve and Chemicals Group. Also, it is supposed that the purchaser will put on sale on the market each floor of the office tower after the purchase. The developer said the gain on disposal would be about HK$14.5 billion, adding that the proceeds of the disposal will be used for general working capital purposes of the group.